{{cartTotalQuantity}}
Menu diagnostyki molekularnej
Aparatura i oprogramowanie
Rozwiązania firmy Cepheid
Na całym świecie
Gospodarka antybiotykami
Cepheid’s Insights
Webinaria
Cepheid RADAR
Support Center
Skontaktuj się z nami
Informacje o spółce Cepheid
Misja i historia
Wydarzenia
Dystrybutorzy
Poznaj motocykl Cepheid
Najnowsze informacje
Nasi liderzy
Kariera
Czas czytania: 5 min
7 stycznia 2026
Czas czytania: 6 min
2 czerwca 2026
Czas czytania: 3 min
2 czerwca 2026
Czas czytania: 6 min
9 września 2026
Artykuł
Researchers analyzing multiplex gastrointestinal (GI) panel results found that multiple E. coli pathotypes were frequently detected alongside other enteric pathogens, potentially complicating data interpretation.
The findings were presented at the Association for Diagnostics & Laboratory Medicine (ADLM) 2026 Clinical Lab Expo.
Key Takeaways
Study Summary
This retrospective analysis used Truveta electronic health record data (53 757 encounters) to evaluate patients tested with multiplex GI panels in acute care settings, including emergency departments and inpatient units. Researchers identified panels using CPT and LOINC codes, then assessed the five most frequent pathogens co-detected with EPEC, EAEC, and ETEC. Co-detection was defined as two or more pathogens reported on a single panel, with prevalence calculated among patients tested for both organisms. The analysis found that E. coli pathotypes were commonly detected with viral and bacterial pathogens. This co-detection can complicate interpretation and may influence inappropriate antibiotic prescribing, especially when the pathogenic role of E. coli is unclear.
The Challenge
Multiplex GI panels can rapidly detect a broad range of organisms, but broad detection can also introduce interpretation challenges. This is especially true when organisms such as EPEC or EAEC may represent colonization rather than the primary cause of symptoms. When these findings appear alongside viral pathogens or other bacteria, clinicians may face uncertainty about which result is clinically actionable.
The Insight
"Detection alone does not always identify the causative pathogen,” said lead study author, Anita Mohandas. “When E. coli pathotypes are found alongside viral or bacterial organisms, clinical context becomes essential for determining whether treatment is warranted."
Conclusion
This study underscores a practical challenge in syndromic GI testing: more detection does not always mean clearer clinical direction. Frequent E. coli co-detections, particularly with viral pathogens, highlight the need for careful interpretation, clinician education, and panel design that prioritizes clinically actionable results.
Abbreviations
EPEC enteropathogenic E. coli; EAEC enteroaggregative E. coli; ETEC enterotoxigenic E. coli; DEC diarrheagenic E. coli; CPT Current Procedural Terminology; LOINC Logical Observation Identifiers Names and Codes
Want to know more?
Authors: Anita Mohandas, MSc, MHPª; Riley Zambrano, MScª; Jordan Chase, BAª; Christophe Martinaud, MD, PhDª
ªCepheid, Sunnyvale, CA, USA
ADLM 2026. Poster A-305
The content presented on this page is intended for informational and educational purposes. While it is available globally, it may reflect clinical practices or healthcare system considerations specific to a particular region.
WIĘCEJ